檢索結果 - Colomer, Ramon
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition 由 Quintela-Fandino, Miguel, Apala, Juan V., Malon, Diego, Mouron, Silvana, Hornedo, Javier, Gonzalez-Cortijo, Lucia, Colomer, Ramon, Guerra, Juan
出版 2019Text -
7
Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its ap... 由 Ciruelos, Eva, Alba, Emilio, López, Rafael, Lluch, Anna, Martín, Miguel, Arroyo, Isabel, Navarro, Beatriz, Carcedo, David, Colomer, Ramón, Albanell, Joan
出版 2019Text -
8
-
9
-
10
Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer 由 Baró, Eva, Carulla, Joan, Cassinello, Javier, Colomer, Ramón, Mata, Jesús García, Gascón, Pere, Gasquet, Jose Antonio, Rodríguez, Cesar A., Valentín, Vicente
出版 2010Text -
11
Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer 由 Martin-Castillo, Begoña, Lopez-Bonet, Eugeni, Buxó, Maria, Dorca, Joan, Tuca-Rodríguez, Francesc, Ruano, Miguel Alonso, Colomer, Ramon, Menendez, Javier A.
出版 2015Text -
12
Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer 由 Grunt, Thomas W., Slany, Astrid, Semkova, Mariya, Colomer, Ramón, López-Rodríguez, María Luz, Wuczkowski, Michael, Wagner, Renate, Gerner, Christopher, Stübiger, Gerald
出版 2020Text -
13
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells 由 Menendez, Javier A, Vazquez-Martin, Alejandro, Colomer, Ramon, Brunet, Joan, Carrasco-Pancorbo, Alegria, Garcia-Villalba, Rocio, Fernandez-Gutierrez, Alberto, Segura-Carretero, Antonio
出版 2007Text -
14
-
15
-
16
EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells Induced By Serum Deprivation: The Modulator Role of PI3K/Akt 由 Martín-Orozco, Rosa M, Almaraz-Pro, Carmén, Rodríguez-Ubreva, F Javier, Cortés, M Alicia, Ropero, Santiago, Colomer, Ramón, López-Ruiz, Pilar, Colás, Begoña
出版 2007Text -
17
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines 由 Puig, Teresa, Aguilar, Helena, Cufí, Sílvia, Oliveras, Glòria, Turrado, Carlos, Ortega-Gutiérrez, Sílvia, Benhamú, Bellinda, López-Rodríguez, María Luz, Urruticoechea, Ander, Colomer, Ramon
出版 2011Text -
18
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1 由 Mouron, Silvana, Manso, Luis, Caleiras, Eduardo, Rodriguez-Peralto, Jose L., Rueda, Oscar M., Caldas, Carlos, Colomer, Ramon, Quintela-Fandino, Miguel, Bueno, Maria J.
出版 2021Text -
19
A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy 由 Sánchez-Alonso, Santiago, Setti-Jerez, Giulia, Arroyo, Montserrat, Hernández, Tathiana, Martos, Mª Inmaculada, Sánchez-Torres, Jose Miguel, Colomer, Ramon, Ramiro, Almudena R, Alfranca, Arantzazu
出版 2020Text -
20
Selective activity over a constitutively active RET‐variant of the oral multikinase inhibitor dovitinib: Results of the CNIO‐BR002 phase I‐trial 由 Quintela-Fandino, Miguel, Bueno, Maria J., Lombardia, Luis, Gil, Marta, Gonzalez-Martin, Antonio, Marquez, Raul, Bratos, Raquel, Guerra, Juan, Tan, Eugene, Lopez, Antonio, Colomer, Ramon, Salazar, Ramon
出版 2014Text